Shared Care Guidelines And Fact Sheets

Drugs which require monitoring

Signposting to available monitoring guidance

NCL Sector Shared Care

Adult ADHD shared care (Methylphenidate, Atomoxetine, Dexamfetamine and Lisdexamfetamine)
Adult ADHD shared care (Methylphenidate, Atomoxetine, Dexamfetamine and Lisdexamfetamine) (MS Word document)
Paediatric ADHD shared care (Methylphenidate, Atomoxetine, Dexamfetamine and Lisdexamfetamine)
Paediatric ADHD shared care (Methylphenidate, Atomoxetine, Dexamfetamine and Lisdexamfetamine) (MS Word document)
Methotrexate shared care
Methotrexate shared care (MS Word document)
Rifaximin shared care (MS Word document)
Rifaximin shared care
Riluzole shared care
Riluzole shared care (MS Word document)
Rufinamide shared care
Rufinamide shared care (MS Word document)
Sativex shared care for multiple sclerosis related spasticity
Sativex shared care for multiple sclerosis related spasticity (MS Word document)

Antipsychotic Monitoring
Ciclosporin fact sheet
Denosumab (Prolia) fact sheet
Disease Modifying Anti-Rheumatic Drugs (DMARDs) Quick Reference Guide
Lacosamide fact sheet
Linaclotide fact sheet
Semaglutide, dulaglutide and liraglutide fact sheet
Lithium fact sheet (adults)
Melatonin factsheet
Midazolam fact sheet
Midazolam care plan (UCLH)
Perampanel fact sheet
Sacubitril valsartan (Entresto) fact sheet

Symptom control Medication Authorisation and Administration Record (MAAR) Chart for subcutaneous and intramuscular medication in the community setting

Symptom control and MAAR chart Policy (V3)
MAAR Chart editable document (V3)
NCL training package